Patients with classical Hodgkin lymphoma experiencing disease progression after treatment with brentuximab vedotin have poor outcomes
Titel:
Patients with classical Hodgkin lymphoma experiencing disease progression after treatment with brentuximab vedotin have poor outcomes
Auteur:
Cheah, C.Y. Chihara, D. Horowitz, S. Sevin, A. Oki, Y. Zhou, S. Fowler, N.H. Romaguera, J.E. Turturro, F. Hagemeister, F.B. Fayad, L.E. Wang, M. Neelapu, S.S. Nastoupil, L.J. Westin, J.R. Rodriguez, M.A. Samaniego, F. Anderlini, P. Nieto, Y. Fanale, M.A.